Baipharm
ChemLinked
Market
Chemical
Food
Cosmetic
BaiPharm
Agrochemical
Japan
LOG IN
SIGN UP
LOG IN
Home
News
Insights
Database
Events
Webinars
Offline Events
Services
Home
News
Insights
Database
Drug Catalog
ChP Standards
Events
Webinars
Offline Events
Services
Search
Insights
In-depth regulation interpretation, authoritative policy insights shared by our experts and specialists.
All
Interpretation
Report
Q&A
All
Interpretation
Report
Q&A
Topic
Regulation
CDE Guideline
Law & Regulation
Pharmacopoeia
Reference Listed Drug (RLD)
Hot topic
Bioequivalence (BE)
Clinical Trial
CMC
CRO
DMF
Drug Registration
GCP
GMP
MAH
Marketing Approval
New Drug
Pharmacovigilance
Post-market
Priority Review and Approval
Policy
Medical Insurance
NRDL
Volume-Based Procurement
Product
API
Biological Product
Biosimilar
Generic Drug
Innovative Drug
OTC Drug
Apply
Cancel
Marketing Approval
INTERPRETATION
Generic Drug Application (ANDA) in China
May 18, 2022
Q&A
FAQ on Rare Disease Drugs (Orphan Drugs) in China
Apr 07, 2022
INTERPRETATION
How to Sell OTC Drugs to China Through Cross-Border E-Commerce
Mar 29, 2022
INTERPRETATION
Drug Application Fees for FY 2022 in China and the U.S.
Feb 11, 2022
INTERPRETATION
China Chemical Drug Registration Classification
Oct 18, 2021
INTERPRETATION
IVD Reagent Registration and Filing in China
Oct 08, 2021
INTERPRETATION
Medical Device Registration and Filing in China
Sep 18, 2021
REPORT
China Drug Evaluation Report 2020-Reform of Drug Review & Approval System
Aug 27, 2021
REPORT
China Drug Evaluation Report 2020-Disapproval Reasons
Aug 27, 2021
REPORT
China Drug Evaluation Report 2020-Critical Numbers
Aug 27, 2021
INTERPRETATION
Expedited Programs for Drug Registration in China
Aug 16, 2021
INTERPRETATION
How Does China's Drug Patent Linkage System Work?
Jul 29, 2021
1
2
Next